Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

GRANROSE

Financiado

Cerrado

Using a blood cell based approach to determine gluten responsiveness and to brin...

Using a blood cell based approach to determine gluten responsiveness and to bring a novel less invasive assay on the market to diagnose celiac disease. Microbiome is a Dutch R&D-performing SME developing molecular diagnostic assays based on human biomarkers with one of its focuses to celiac disease diagnostics. We developed a molecular diagnostic assay to screen HLA genotypes tha... ver más

14/10/2020

ROBSONS INTERNATIO...

130K€

Presupuesto del proyecto: 130K€

Líder del proyecto

ROBSON MICHAEL ALAN No se ha especificado una descripción o un objeto social para esta compañía.

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2020-10-14

INNOSUP-02-2019-2020: European SME innovation Associate -...

I+D

Cerrada hace 6 años

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

ROBSONS INTERNATIONAL RAIL C...

130.06K€ | Lider

Proyectos interesantes

ECLOBIOSENS

Medical Technol...

Data Science

162K€ Cerrado

CD-MB

Medical Technol...

Nanotechnology

30K€ Cerrado

CD-HLASENS

Medical Technol...

Nanotechnology

45K€ Cerrado

SAF2017-91873-EXP

Medical Technol...

36K€ Cerrado

TRANSVASCED

Medical Technol...

Data Science

45K€ Cerrado

AUTO-CD

Medical Technol...

2M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 13 meses Fecha Inicio: 2019-09-11
Fecha Fin: 2020-10-14

Líder del proyecto

ROBSON MICHAEL ALAN No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 130K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Microbiome is a Dutch R&D-performing SME developing molecular diagnostic assays based on human biomarkers with one of its focuses to celiac disease diagnostics. We developed a molecular diagnostic assay to screen HLA genotypes that are known to be associated with celiac disease (CD). Up to date, CD is diagnosed by serology (e.g. the presence of auto-antibodies to tissue transglutaminase 2 in the serum) and diagnosis requires further proof by analysis of a duodenal biopsy specimen. The collection of biopsy specimens requires an invasive examination and correct embedding of the tissue is essential for proper analysis of the tissue. This part of CD diagnosis is expensive, elaborate and prone to mistake. Innovation that trustworthy and efficiently can replace biopsy is in high demand. GRANROSE will enable Microbiome to strengthen its position as an innovative biotech SME, developing a novel assay, NeutroScan, for the CD market. GRANROSE will do this through hiring an Innovation Associate (IA). • The IA will confirm and complete a biomarker panel that plays a role in gluten-related neutrophil function. • The IA will develop an assay to study neutrophil function in gluten-related disease. • The IA will perform a technical feasibility study for and investigate the market potential of the NeutroScan, an assay distinguishing gluten-related disease based on neutrophil function. GRANROSE will not only bring major benefits for Microbiome, but is focused around the training of the Innovation Associate, thereby greatly improving his/her career development. • Gaining novel technical skills and building an own research line with translational diagnostic applications. • Gaining innovation and business management skills in a multidisciplinary setting. • A training program tailored to his/her specific needs and major contribution to personal career development.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores